T3 Pharmaceuticals

Switzerland
Breíl, Grisons, Switzerland, BS 4056

Company profile

T3 Pharmaceuticals company profile

The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria.

Business identity

Contact email
[email protected]
Phone number
+410612672074
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2015-01-01, Year

Headquarters

Postal code
BS 4056
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
5
Total equity funding
$39M
Last funding
Grant / 2023-04-28
Last equity funding
Series C / $26.9M
Investors
6
Lead investors
5
Founders
2
Articles
10
Exited on
2023-11-22

Founders and investors

Founders

Christoph KasperSimon J. Ittig

Lead investors

Boehringer Ingelheim Venture FundInnosuisseSwiss Economic AwardSwiss Federal Commission for Innovation and TechnologyWille Finance

Investors

Boehringer Ingelheim Venture FundInnosuisseReference Capital SASwiss Federal Commission for Innovation and TechnologyWille Finance